Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression

Junye Liu1, Le Yang, Jian Zhang

  • 1Department of Radiation Medicine, Fourth Military Medical University, Xi'an, China.

BMC Cancer
|August 28, 2012
PubMed
Abstract

Insights

Down-regulating NDRG2 (N-Myc downstream regulated gene 2) enhances cervical cancer Hela cells' sensitivity to cisplatin chemotherapy. This occurs by increasing apoptosis via the miR-15b/miR-16 pathway, which downregulates Bcl-2 protein expression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • NDRG2 (N-Myc downstream regulated gene 2) is implicated in stress response, differentiation, and tumor suppression.
  • NDRG2 expression significantly increases in cervical cancer Hela cells treated with cisplatin.
  • This observation prompted an investigation into NDRG2's role in Hela cell chemosensitivity.

Purpose of the Study:

  • To evaluate the role of NDRG2 in cisplatin chemosensitivity of cervical cancer Hela cells.
  • To elucidate the molecular mechanisms underlying NDRG2's influence on chemosensitivity.
  • To determine if NDRG2 modulation affects cisplatin-induced apoptosis and related protein expression.

Main Methods:

  • RNA interference was used to down-regulate NDRG2 expression in Hela cells.
  • RT-PCR and Western blot analyzed NDRG2, Bcl-2, and Bax expression.
  • Real-time PCR quantified miR-15b and miR-16 levels.
  • MTT assays assessed drug sensitivity, colony-forming assays evaluated cloning efficiency, and flow cytometry detected apoptosis.

Main Results:

  • Suppression of NDRG2 sensitized Hela cells to cisplatin in vitro.
  • NDRG2 down-regulation promoted cisplatin-induced apoptosis without affecting colony-forming ability.
  • Inhibition of NDRG2 led to decreased Bcl-2 protein levels, but not mRNA levels.
  • miR-15b and miR-16 were significantly up-regulated in NDRG2-suppressed Hela cells.

Conclusions:

  • Down-regulation of NDRG2 enhances Hela cell sensitivity to cisplatin.
  • This sensitization is mediated by the inhibition of Bcl-2 protein expression.
  • Upregulation of miR-15b and miR-16 likely mediates the observed effects on Bcl-2.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...